Polymorphisms in the cytotoxic T lymphocyte-associated protein-4 immune regulatory gene and their impact on inhibitor development in patients with hemophilia A

OBJECTIVE: The development of inhibitors against infused factor VIII represents the most severe complication of substitution therapy in hemophilia A (HA) patients. Data on risk factors for inhibitor formation in Iraqi Kurdish patients with HA are unavailable. This study aimed to evaluate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulqader, Aveen M. Raouf, Mohammed, Ali Ibrahim, Rachid, Shwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833422/
https://www.ncbi.nlm.nih.gov/pubmed/31524022
http://dx.doi.org/10.1177/0300060519860329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833422/
https://www.ncbi.nlm.nih.gov/pubmed/31524022
http://dx.doi.org/10.1177/0300060519860329

Ejemplares similares